In the original article, an error occurred in Figure 1E. The median ABC [x10³ binding sites/cell] for anti-FcγRI on neutrophils was shown as “71”. The correct number is “<1”, in agreement with the data presented in Figure 1A and deposited in the Figshare repository as well as the description in the text that among peripheral blood leukocytes of mice expression of FcγRI is restricted to monocytes. The corrected Figure 1E appears below.
Figure 1

Fc gamma receptors on murine peripheral blood leukocytes. Depicted are box plots showing anti-FcR binding sites for (A) FcγRI, (B) FcγRIIb, (C) FcγRIII, and (D) FcγRIV on indicated leukocyte subsets together with (E) a tabular presentation of the median number of binding sites. n = 15–41 from 4 to 11 independent experiments.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
Fc receptors, antibodies, human leukocytes, murine leukocytes, quantification, receptor numbers, neutrophils, monocytes
Citation
Kerntke C, Nimmerjahn F and Biburger M (2022) Corrigendum: There Is (Scientific) Strength in Numbers: A Comprehensive Quantitation of Fc Gamma Receptor Numbers on Human and Murine Peripheral Blood Leukocytes. Front. Immunol. 12:840026. doi: 10.3389/fimmu.2021.840026
Received
20 December 2021
Accepted
31 December 2021
Published
20 January 2022
Volume
12 - 2021
Edited and reviewed by
Latha P. Ganesan, The Ohio State University, United States
Updates
Copyright
© 2022 Kerntke, Nimmerjahn and Biburger.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Falk Nimmerjahn, falk.nimmerjahn@fau.de; Markus Biburger, markus.biburger@fau.de
This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.